Quentin E. Adams

University of Iowa

Papers

1

Total Citations

10

H-Index

1

About

Quentin E. Adams is a pioneering researcher in the field of medical physics and radiation oncology, with a primary focus on advancing brachytherapy techniques for cancer treatment. His most notable contribution is the development of a novel 169Yb-based rotating shield brachytherapy (RSBT) system for prostate cancer, which enables a single-fraction treatment regimen using a single-catheter robotic delivery system. This innovative approach allows for highly conformal dose delivery through multiple implanted needles, significantly improving treatment precision while reducing procedure time. Adams' work has garnered attention in the radiation oncology community, with his seminal 2020 paper accumulating 10 citations as a foundational reference in the field. His research addresses critical challenges in prostate cancer therapy by combining isotope selection with dynamic shielding technology, offering potential advantages over conventional high-dose-rate brachytherapy. Adams' contributions represent a significant step toward more efficient and patient-friendly cancer treatments, positioning him as an emerging thought leader in the evolution of image-guided adaptive brachytherapy.

Research Focus

Key Achievements

1
H-Index
1
Papers
10
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
<sup>169</sup>Yb‐based rotating shield brachytherapy for prostate cancer
10 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Iowa

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago